Bayesian Capital Management, LP Nuvation Bio Inc. Transaction History
Bayesian Capital Management, LP
- $854 Million
- Q2 2024
A detailed history of Bayesian Capital Management, LP transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 46,300 shares of NUVB stock, worth $110,657. This represents 0.02% of its overall portfolio holdings.
Number of Shares
46,300Holding current value
$110,657% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding NUVB
# of Institutions
151Shares Held
123MCall Options Held
9.7KPut Options Held
6.5K-
Eco R1 Capital, LLC San Francisco, CA19.2MShares$45.9 Million1.98% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$38.8 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.3MShares$31.7 Million50.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$24.2 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA6.95MShares$16.6 Million6.22% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $519M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...